Pharmacists Expand Access to Reproductive heaLthcare (PEARL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03830567|
Recruitment Status : Active, not recruiting
First Posted : February 5, 2019
Last Update Posted : March 23, 2021
|Condition or disease||Intervention/treatment|
|Contraception||Other: Pharmacist prescription Other: Clinician prescription|
Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription.
This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.
|Study Type :||Observational|
|Actual Enrollment :||471 participants|
|Official Title:||Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception|
|Actual Study Start Date :||January 27, 2019|
|Actual Primary Completion Date :||February 2, 2021|
|Estimated Study Completion Date :||October 2022|
Other: Pharmacist prescription
Pharmacist prescribed hormonal contraception (initiation or continuation).
Other: Clinician prescription
Clinician prescribed hormonal contraception (initiation or continuation).
- Contraceptive continuation rates [ Time Frame: 12 months ]Percentage of contraceptive continuation assessed through survey at 12 months among women who present for contraception in pharmacies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03830567
|United States, Oregon|
|Oregon Health & Science University|
|Portland, Oregon, United States, 97239|
|Principal Investigator:||Maria I Rodriguez, MD, MPH||Oregon Health and Science University|